MONTREAL, Jan. 14 /CNW Telbec/ - Steve Saviuk, President and CEO of Valeo Pharma, is pleased to announce the appointment of Mr. Richard J. (Dick) MacKay to the position of Chairman of Valeo Pharma.
Mr. MacKay joins Valeo Pharma following his retirement from Stiefel, where he held the positions of Vice-Chairman of the Board of Directors of Stiefel Laboratories, and President of Stiefel Canada.
Mr. MacKay brings a wealth of experience and achievement to Valeo Pharma, having been a key player in the Canadian pharmaceutical industry over the course of an illustrious career.
Richard MacKay's experience in building strategic alliances and developing business in the Canadian dermatology market will be of great benefit to Valeo Pharma.
Valeo Pharma, a Canadian company established in 2003, is committed to providing health care professionals and patients with high quality specialty pharmaceutical products.
SOURCE VALEO PHARMA INC.
For further information: For further information: Marc Leger, (514) 693-8849